Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer.

Feb 21, 2024 · Enzalutamide is a prescription medicine used to treat prostate cancer in men who have received surgery or hormone therapy to lower testosterone. Enzalutamide is sometimes …

XTANDI (enzalutamide) is a prescription medicine used to treat men with prostate cancer that: no longer responds to a hormone therapy or surgical treatment to lower testosterone OR has …

Dec 14, 2023 · Enzalutamide is an anticancer (antineoplastic) medication used in the treatment of prostate cancer in adult males. Prostate is a walnut-sized gland located below the bladder that …

Enzalutamide Gets Added Approval for Prostate Cancer That Hasn’t Spread. FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers. Targeted Cancer Therapies. …

Easy-to-read patient leaflet for Enzalutamide. Includes indications, proper use, special instructions, precautions, and possible side effects. Skip to main content

Enzalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of …

Mar 25, 2024 · Detailed Enzalutamide dosage information for adults. Includes dosages for Prostate Cancer; plus renal, liver and dialysis adjustments.

Enzalutamide is used to treat prostate cancer. This medication belongs to a class of drugs known as anti-androgens (anti- testosterone). It works by blocking the effects of testosterone to...

XTANDI® is indicated for the treatment of patients with castration-resistant prostate cancer (CRPC). The recommended dose of XTANDI is 160 mg (four 40 mg capsules) administered …